AWS GraphRAG deployment cuts drug research cycles by 87%
A recent AWS GraphRAG deployment reduced drug research and development cycles in pharmaceutical environments by 87 percent. This acceleration is achieved by integrating previously separated proprietary databases into a unified and queryable knowledge graph. Historically, initial data gathering and screening phases took over six months per iteration, yielding a low five percent success rate. Crucial […] The post AWS GraphRAG deployment cuts drug research cycles by 87% appeared first on AI News.